Baudax Bio, Inc.
490 Lapp Rd.
Malvern, Pennsylvania 19355
September 21, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
| Re: | Baudax Bio, Inc. |
Registration Statement on Form S-3 (File No. 333-272994) |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Baudax Bio, Inc. (the “Company”) hereby requests that the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-272994) (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective at 9:30 AM, eastern time, on September 25, 2023, or as soon as thereafter as is practicable.
Please contact Jennifer Porter, Esq. of Goodwin Procter LLP, counsel to the Company, at (445) 207-7806 to provide notice of effectiveness, or if you have any questions or comments concerning this request.
[Remainder of the page intentionally left blank]
1
Very truly yours,
| BAUDAX BIO, INC. | ||
| By: | /s/ Gerri A. Henwood | |
Name: Gerri A. Henwood | ||
Title: Chief Executive Officer | ||
Baudax Bio, Inc. — Acceleration Letter